openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of RenovaCare, Inc. (OTC: RCAR)

10-05-2021 06:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in RenovaCare, Inc. (OTC: RCAR) shares.

An investigation on behalf of current long term investors in RenovaCare, Inc. (OTC: RCAR) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of RenovaCare, Inc..

Investors who are current long term investors in RenovaCare, Inc. (OTC: RCAR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in OTC: RCAR stocks follows a lawsuit filed against RenovaCare, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: RCAR stocks, concerns whether certain RenovaCare directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that the Defendants failed to disclose to investors that, at the direction of Rayat, RenovaCare engaged in a promotional campaign to issue misleading statements to artificially inflate the Company’s stock price, that, when the OTC Markets inquired, RenovaCare and Rayat issued a materially false and misleading press release claiming that no director, officer, or controlling shareholder had any involvement in the purported third party’s promotional materials, that, as a result of the foregoing, the Company’s disclosure controls and procedures were defective, and as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Those who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of RenovaCare, Inc. (OTC: RCAR) here

News-ID: 2418222 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for RenovaCare

Burns Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight A …
DelveInsight's "Burns Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Burns, historical and forecasted epidemiology as well as the Burns market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Burns market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Burns Market Forecast https://www.delveinsight.com/sample-request/burns-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Burns Market Report:
Burns Market is Expected to Expand at a Healthy Growth Rate During the Forecast …
The Key Burns Companies in the market include - Kerecis, Mallinckrodt Pharmaceuticals, Skingenix, RenovaCare, CUTISS AG, Argle Therapeutics, Medline Industries, Amryt Pharma, MediWound Ltd, MediWound Ltd, Cumberland Pharmaceuticals, Pfizer, Kuros Biosurgery AG, Bayer, and others. DelveInsight's "Burns Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Burns, historical and forecasted epidemiology as well as the Burns market trends in the United States, EU4 (Germany, Spain, Italy, France)
Polymers Drug Delivery Market Size, Scope And Growth Analysis Forecast 2028 | Ac …
Polymers Drug Delivery Market is an vital source of information which gives recent and upcoming technical and financial details about the industry. All composed market statistics data is verified and legal by industry specialists for readers and end users. It develops easy to analyze the actions of key players and their effects on sales, imports-exports, revenues and CAGR values ​​with this credible marketing report. Furthermore, companies in the report are
OTC: RCAR Investor Alert: Deadline on September 14, 2021 in Lawsuit against Reno …
A deadline is coming up on September 14, 2021 in the lawsuit filed for certain investors of RenovaCare, Inc. (OTC: RCAR) over alleged securities laws violations by RenovaCare, Inc. Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and there are strict and short deadlines running. Deadline: September 14, 2021. OTC: RCAR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of RenovaCare, Inc. (OTC: RCAR)
An investor, who purchased shares of RenovaCare, Inc. (OTC: RCAR), filed a lawsuit over alleged violations of Federal Securities Laws by RenovaCare, Inc.. Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR) have certain options and for certain investors are short and strict deadlines running. Deadline: September 14, 2021. OTC: RCAR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Roseland, NJ based RenovaCare, Inc., a development-stage
Investigation announced for Investors in RenovaCare, Inc. (OTC: RCAR)
An investigation was announced concerning potential securities laws violations by RenovaCare, Inc. in connection with certain financial statements was announced. Investors who purchased shares of RenovaCare, Inc. (OTC: RCAR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by RenovaCare, Inc. regarding its business, its prospects and its operations were materially